Early research (Phase 1)Study completedNCT06375512
What this trial is testing
Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
Who this might be right for
Herpes Zoster
Shenzhen Shenxin Biotechnology Co., Ltd 150